Authors

Latest:

Advice for New Nurse Practitioners Working With Patients With Endometrial Cancer

Closing their discussion, the panel shares advice for new nurse practitioners caring for patients who have endometrial cancer.

Katherine L. Nathanson, MD

Latest:

Dr Nathanson on BRCA1/2 Reversion Mutations in Response to Therapy in Breast Cancer

Katherine L. Nathanson, MD, discusses the identification of reversion mutations in BRCA1/2 in response to therapy among patients with breast cancer.

Alyson B. Moadel-Robblee, PhD

Latest:

Evolving Psychosocial Care Models Step Forward as the Next Targeted Cancer Therapy

During this search for a breast cancer support system, my mother also investigated complementary therapies that peers had used to help cope with their fears, adverse effects, and feelings of helplessness.

Cindy Medina Pabon, MD

Latest:

Dr Pabon on the FDA Approval of Zolbetuximab for CLDN18.2+ Gastric/GEJ Adenocarcinoma

Cindy Medina Pabon, MD, discusses the clinical relevance of the FDA approval of zolbetuximab for CLDN18.2-positive gastric or GEJ adenocarcinoma.

Tapan M. Kadia, MD

Latest:

Dr Kadia on Targeting the IRAK4 Pathway in AML

Tapan M. Kadia, MD, discusses targeting the IRAK4 pathway in patients with acute myeloid leukemia and highlights the importance of utilizing targeted therapies in the treatment of patients with hematologic malignancies.

Laura Farrington, DO

Latest:

Women in Oncology: Lessons to Tell Up-and-Coming Female Oncologists

Laura Farrington, DO, Elesyia Outlaw-Evans, MD, and Ruchi Garg, MD, provide advice to female oncologists who are just starting out their careers.

Mariya Rozenblit, MD

Latest:

Dr Rozenblit on Pembrolizumab Outcomes by TMB Status in HR+ Metastatic Breast Cancer

Mariya Rozenblit, MD, discusses how genomic alterations and TMB influence the efficacy of immune checkpoint inhibitors in HR+ metastatic breast cancer.

Jay Moon Lee, MD

Latest:

Dr. Lee on the Current State of Molecular Testing in Early-Stage NSCLC

Jay Moon Lee, MD, discusses the current state of molecular testing in early-stage non–small cell lung cancer.

Angela J. Keleher, MD

Latest:

Breast Nerve Preservation and Grafting: How Surgeons Can Help Mitigate Sensation Loss

More surgeons are having in-depth conversations with their patients with breast cancer and prophylactic patients about the fact that nerves will have to be cut during their mastectomy, how that will impact sensation and quality of life, and how surgeon collaboration and breast neurotization can help restore sensation.

Nicole Odzer

Latest:

Odzer on ERBB2 Copy Number Ratio as a Predictive Biomarker in HER2+ Breast Cancer

Nicole Odzer discusses the utility of ERBB2 copy number ratio as a predictive biomarker in HER2+ breast cancer.

Gail J. Roboz, MD

Latest:

Women in Oncology: Prioritization and Passionate Legacies

Selina M. Luger, MD, FRCPC, Gail J. Roboz, MD, and Wendy Stock, MD, discuss how being female affected their careers and share the scientific achievements they most want to be remembered for in the leukemia field.

Nicoletta Colombo, MD, PhD, Istituto Europeo di Oncologia

Latest:

Dr. Colombo on the Next Steps With Pembrolizumab in Cervical Cancer

Nicoletta Colombo, MD, PhD, discusses the next steps with pembrolizumab in cervical cancer.

Olalekan O. Oluwole, MBBS, MD

Latest:

Dr Oluwole on the Use of CAR T-Cell Therapy in Autoimmune Disorders

Olalekan O. Oluwole, MBBS, MD, discusses the feasibility of using CAR T-cell therapy in patients with nonhematologic autoimmune disorders.

Jessica Altman, MD

Latest:

Women in Oncology: The Value of Female Leadership

Courtney DiNardo, MD, MSCE; Eunice Wang, MD; and Jessica Altman, MD, discuss how they turned career obstacles into opportunities and what they have learned from being women in the leukemia field.

Michelle Miran Kim, MD

Latest:

Dr. Kim on Optimizing Individualized Treatment in Cancer Care

Michelle Miran Kim, MD, discusses optimizing individualized treatment in cancer care.

Jamie Carroll, APRN, CNP, MSN

Latest:

Novel Clinical Trials With ADCs in Gastric Cancer

Before closing out their discussion on HER2+ gastric cancer, experts review clinical trials investigating other novel ADC agents in this setting.

Elyse Lower, MD

Latest:

Dr. Lower on the Importance of Tucatinib Plus Capecitabine/Trastuzumab in HER2+ Breast Cancer

Elyse Lower, MD, discusses the importance of tucatinib in the treatment of patients with HER2-positive breast cancer.

Melissa Zinszer, PharmD, CDCES

Mahasweta Gooptu, MD

Latest:

Monitoring and Follow-Up of Patients with Chronic GVHD

The panel closes by reviewing the patient case once more and shares clinical pearls on the treatment of patients with GVHD.

Roberto Iacovelli, MD, PhD

Latest:

Dr. Iacovelli on Eligibility Criteria of the ARIES Trial in Urothelial Cancer

Roberto Iacovelli, MD, PhD, discusses the patient eligibility criteria of the phase 2 ARIES trial in urothelial cancer.